The study indicated that decreased intratumoral cDC1s and circulating cDC1s in patients with CRC are related to disease stage, whereas suppressed cDC1 gene signature expression in human CRC is associated with a poor prognosis (56). The gene discussed is MPPE1; the disease is colorectal carcinoma.